Observing Barrett's Esophagus with Dysplasia and Early Cancer
Australian Barrett's Cohort With Dysplasia and Early Cancer Study
This study looks at how patients with Barrett's esophagus, especially those with serious changes or early cancer, are managed over time to see how their condition progresses and how well treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Western Sydney Local Health District Academic / other |
| Locations | 1 site (Westmead, New South Wales) |
| Trial ID | NCT02198976 on ClinicalTrials.gov |
What this trial studies
This study aims to collect observational data on the management and outcomes of patients with Barrett's esophagus who have high-grade dysplasia or intramucosal carcinoma. It also seeks to understand the natural history of patients with low-grade dysplastic and non-dysplastic Barrett's esophagus. By monitoring these patients over time, the study will provide insights into disease progression and treatment effectiveness.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with Barrett's esophagus.
Not a fit: Patients under 18 years old or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and treatment strategies for patients with Barrett's esophagus, potentially leading to better outcomes.
How similar studies have performed: While observational studies on Barrett's esophagus exist, this specific cohort approach focusing on dysplasia and early cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can give informed consent to trial participation * Age greater than 18 * Barrett's oesophagus Exclusion Criteria: * Age less than 18 * Pregnant patients
Where this trial is running
Westmead, New South Wales
- Westmead Endoscopy Unit — Westmead, New South Wales, Australia (Recruiting)
Study contacts
- Principal investigator: Michael J Bourke, MBBS — Western Sydney Local Health District
- Study coordinator: Michael Bourke, MBBS
- Email: michael@citywestgastro.com.au
- Phone: 88905555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.